EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Coxsackievirus B3 infects and disrupts human induced-pluripotent stem cell derived brain-like endothelial cells

Julia Mamana, Gabrielle M Humber, Eric R Espinal, Soojung Seo, Nadine Vollmuth, Jon Sin, Brandon J Kim

Frontiers in Cellular and Infection Microbiology · 17.04.2023 · 13

DOI: 10.3389/fcimb.2023.1171275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 17.04.2023. Verfasst von Julia Mamana und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, United States. Hauptthemen laut MEDLINE: Coxsackievirus Infections, Enterovirus, Pluripotent Stem Cells. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coxsackievirus B3 (CVB3) is a significant human pathogen that is commonly found worldwide. CVB3 among other enteroviruses, are the leading causes of aseptic meningo-encephalitis which can be fatal especially in young children. How the virus gains access to the brain is poorly-understood, and the host-virus interactions that occur at the blood-brain barrier (BBB) is even less-characterized. The BBB is a highly specialized biological barrier consisting primarily of brain endothelial cells which possess unique barrier properties and facilitate the passage of nutrients into the brain while restricting access to toxins and pathogens including viruses. To determine the effects of CVB3 infection on the BBB, we utilized a model of human induced-pluripotent stem cell-derived brain-like endothelial cells (iBECs) to ascertain if CVB3 infection may alter barrier cell function and overall survival. In this study, we determined that these iBECs indeed are susceptible to CVB3 infection and release high titers of extracellular virus. We also determined that infected iBECs maintain high transendothelial electrical resistance (TEER) during early infection despite possessing high viral load. TEER progressively declines at later stages of infection. Interestingly, despite the high viral burden and TEER disruptions at later timepoints, infected iBEC monolayers remain intact, indicating a low degree of late-stage virally-mediated cell death, which may contribute to prolonged viral shedding. We had previously reported that CVB3 infections rely on the activation of transient receptor vanilloid potential 1 (TRPV1) and found that inhibiting TRPV1 activity with SB-366791 significantly limited CVB3 infection of HeLa cervical cancer cells. Similarly in this study, we observed that treating iBECs with SB-366791 significantly reduced CVB3 infection, which suggests that not only can this drug potentially limit viral entry into the brain, but also demonstrates that this infection model could be a valuable platform for testing antiviral treatments of neurotropic viruses. In all, our findings elucidate the unique effects of CVB3 infection on the BBB and shed light on potential mechanisms by which the virus can initiate infections in the brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coxsackievirus InfectionsEnterovirusPluripotent Stem CellsChildHumansChild, PreschoolEndothelial CellsHeLa CellsBrainEnterovirus B, HumanVirus Replication

Stichwörter der Autor:innen

blood brain barrierbraincoxsackievirus B3stem cellsvirus

Autor:innen und Institutionen

  • Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, United States.
  • Department of Microbiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
  • Center for Convergent Biosciences and Medicine, University of Alabama, Tuscaloosa, AL, United States.
  • Alabama Life Research Institute, University of Alabama, Tuscaloosa, AL, United States.

Förderung

  • NIDDK NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Mamana, J., Humber, G. M., Espinal, E. R., Seo, S., Vollmuth, N., Sin, J., & Kim, B. J. (2023). Coxsackievirus B3 infects and disrupts human induced-pluripotent stem cell derived brain-like endothelial cells. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1171275

Vancouver

Mamana J, Humber GM, Espinal ER, Seo S, Vollmuth N, Sin J, et al. Coxsackievirus B3 infects and disrupts human induced-pluripotent stem cell derived brain-like endothelial cells. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1171275

BibTeX
@article{Mamana2023,
  author = {Mamana, Julia and Humber, Gabrielle M and Espinal, Eric R and Seo, Soojung and Vollmuth, Nadine and Sin, Jon and Kim, Brandon J},
  title = {Coxsackievirus B3 infects and disrupts human induced-pluripotent stem cell derived brain-like endothelial cells},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fcimb.2023.1171275}
}
Kostenlos starten →